Skip to main content
. 2021 Nov 9;60:255–262. doi: 10.1016/j.breast.2021.11.004

Table 5.

Univariate analysis of variables with progression.

Variables Reference HR LCI (95%CIHR) UCI (95%CIHR) p-value
OncotypeDx® RS low 0
RS intermediate 1 0.973 0.088 10.735 0.982
RS high 2 4.871 0.387 61.359 0.221
Mammaprint® Low 0
High 1 0.497 0.095 2.612 0.409
Age(years) ≤50 1 1.608 0.424 6.101 0.485
>50 0
Grade G1 0
G2 1 0.53 0.151 0.41 0.321
G3 2 0.986
Lymphovascular invasion Positive 0
Negative 1 1.291 0.155 10.742 0.813
Lymph nodes N0 1 0.838 0.178 3.953 0.823
N1/N1mi 1 1.227 0.26 5.787 0.796
Subtype luminal A 0
B 1 0.191 0.041 0.902 0.037
Margins R1 1 4.364 1.311 14.528 0.016
R0 0 0 0 0
Ki 67 ≤20% 0
>20% 1 0.412 0.087 1.944 0.262
Type of treatment Surgery + RT 1 0.949 0.201 4.473 0.947
Surgery 0
Systemic treatment HT 0
QT + HT 1 1.251 0.366 4.273 0.721

Abbreviations: Surgery (Lumpectomy; Mastectomy), QT (Chemotherapy), HT (hormone therapy).